Page 6 - Tomki News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tomki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tomki Today - Breaking & Trending Today
PUTRAJAYA: The Malaysian Islamic Development Department (Jakim) will abide by the decree issued by the Sultan of Selangor, Sultan Sharafuddin Idris Shah that the department cannot issue any statement regarding the decisions made by the Muzakarah Committee of the National Council for Islamic Religious Affairs (MKI), says the department director-general Datuk Hakimah Mohd Yusoff. ....
KUALA LUMPUR: The position of the chairman of the National Council for Islamic Religious Affairs (MKI) will now be held by one of the ruling monarchs in rotation for two years with the prime minister as his deputy, says Minister in the Prime Minister’s Department (Religious Affairs) Datuk Idris Ahmad. ....
MELAKA - Mesyuarat Jawatankuasa Muzakarah Khas Majlis Kebangsaan Bagi Hal Ehwal Ugama Islam Malaysia (MKI) pada Rabu telah memuktamadkan draf pelaksanaan prosedur operasi standard (SOP) berkaitan solat berjemaah di masjid dan surau. Menteri di Jabatan Perdana Menteri (Hal Ehwal Agama), Senator Idris Ahmad berkata, hasil muzakarah disertai mufti-mufti di seluruh negeri yang diputuskan itu merupakan panduan dan akan diserahkan kepada jabatan agama negeri masing-masing. Bagaimanapun, menurutnya, Jabatan Kemajuan Islam Malaysia (Jakim) hanya menjadi penyelaras termasuk memberikan pandangan, namun segala ketetapan berkaitan solat jemaah termasuk kuota jemaah yang dibenarkan adalah di bawah bidang kuasa agama setiap negeri dan terpulang kepada mereka untuk melaksanakan SOP berkenaan. ....
Glenmark launches affordable drug to treat kidney cancer in India Glenmark launches affordable drug to treat kidney cancer in India 16 February 2021 | News The drug is launched at a MRP that is approximately 96 per cent lower than the MRP compared to the innovator brand, priced at Rs 7000 (50 mg), Rs 3600 (25 mg) and Rs 1840 (12.5 mg) per month Source credit: Shutterstock Glenmark Pharmaceuticals has launched SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in India. The drug is launched at a MRP that is approximately 96 per cent lower than the MRP compared to the innovator brand, priced at Rs 7000 (50 mg), Rs 3600 (25 mg) and Rs 1840 (12.5 mg) per month. Sunitinib is also approved by the US Food and Drug Administration (US FDA). ....